Clinigen Share Discussion Threads

[nw99] 10/6/2021 07:36

Possible bid on the cards picked some up early doors

[johnrxx99] 10/6/2021 07:30

In it, nose and rub come to mind. Thanks for your contribution P1945. Was that the end of the conflict?

[r2oo] 10/6/2021 07:05

Some pretty big trades going through out of hours look like sells too!

[maverick081267] 09/6/2021 15:48

Dipped in to in the last few mins

[slinkyj] 09/6/2021 15:12

Dipped me toes in the water here.

[r2oo] 09/6/2021 14:58

I am very tempted to top up at these levels although you tend to see a couple more days of smaller declines after a huge drop like this before the bounce.

[johnrxx99] 09/6/2021 14:54

The EBITDA reduction is about 11% based on average figures of analysts.

[pennypincher5] 09/6/2021 10:36

IMHO proleukin is a huge risk and has saddled company with a level of debt it seems unable to shift. Time will tell if this pays off. It’s largely out of Clinigen’s hands given it relies on 3rd parties to find new indications (such as Iovance). Investors should look to past performance on other products and the service side of business as well as proleukin - however changes in reporting year on year make this difficult.

[hjs] 09/6/2021 09:50

Imo- the share price drop today is just a blip. I am already invested. It is a very good opportunity to add some more or new investors to buy this stock.
Value V- you may be right, private equity may run a slide rule now and grab a bargain. This is covid impacted stock and will recover as soon as we open up.

[value viper] 09/6/2021 09:00

HhmmPrivate equity will be more interested now imv - think needs some boardroom changes Advent was rumoured last summer to have been slide ruling

[ali47fish] 09/6/2021 08:59

what do you oxman?

[its the oxman] 09/6/2021 08:52

600p is the obvious target here. How close will we get?

[theprovosts] 09/6/2021 08:36

What did they miss EBIDTA estimates by?

"now expected that adjusted EBITDA 2 will be within the range of £114m-£117m for the full year 2021"

Edit. MarketScreener had estimated £131.

[nw99] 09/6/2021 08:36

Buyer at 600

[johnrxx99] 09/6/2021 07:40

averaged down - fingers crossed. I think 20%+ is a bit overdone.

[r2oo] 09/6/2021 07:39

I see this as a temporary blip and a buying opportunity for a solid companyI'll be topping up when the dust settles.

[robertball] 09/6/2021 07:23

Not really

[bulltradept] 09/6/2021 07:22

Temporary weakness...

[whatja] 04/6/2021 16:24

Anyone have views on Iovance and their TIL product? Things don’t look good as fda knocked back assays again.

[johnrxx99] 04/6/2021 15:26

Looks undervalued in a growth sector. <1 PEG of next 2 years and low PE and reasonable EV/EBITDA of 11. My kind of stock.

[whatja] 04/6/2021 12:00

Because there is not much to debate...

There have been some small contracts announced but

There needs to be news about Proleukin and Erwinase.

I would have thought the offer for UDG would create a ripple here as it has some similar business.

What do you think of the share Johnr?

[johnrxx99] 04/6/2021 08:52

Why so nice and quiet?